Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adriamycin Toxicity”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Not applicableStudy completedNCT06595758
What this trial is testing

This Study Investigates the Impact of Single Nucleotide Polymorphisms in Genes Involved in the Pharmacokinetics and Toxicity of Doxorubicin (DOX) in Egyptian Female Patients with Breast Cancer. It Also Aims to Explore the Association of Pretreatment Neutrophil to Lymphocyte Ratio to PCR

Who this might be right for
Breast Cancer
Menoufia University 100
Not applicableStudy completedNCT00875238
What this trial is testing

Side Effects Involving the Heart in Women With Breast Cancer Receiving Doxorubicin and Trastuzumab

Who this might be right for
Breast CancerCardiac ToxicityCardiovascular Complications
Vanderbilt University 133
Testing effectiveness (Phase 2)Ended earlyNCT02096588
What this trial is testing

Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin

Who this might be right for
Breast CancerStage I Breast CancerStage II Breast Cancer+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 34
Post-approval studies (Phase 4)UnknownNCT05302336
What this trial is testing

AC vs TC in Patients With HR-positive, HER2-negative Early Breast Cancer

Who this might be right for
Breast CancerChemotherapeutic Toxicity
Second Affiliated Hospital, School of Medicine, Zhejiang University 402
Not applicableUnknownNCT04581967
What this trial is testing

Study of CYP2C19 and ALDH3A1 Polymorphisms in Breast Cancer Patients

Who this might be right for
Breast Cancer Patients
Damanhour University 100
Testing effectiveness (Phase 2)Study completedNCT00436566
What this trial is testing

Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery

Who this might be right for
Breast CancerCardiac Toxicity
Mayo Clinic 122
Early research (Phase 1)Study completedNCT03930680
What this trial is testing

Prevention of Heart Failure Induced by Doxorubicin With Early Administration of Dexrazoxane

Who this might be right for
Degradation of Top2b and Top2a in Human by DexrazoxaneTime Course and Degradation of Top2b in Human by DexrazoxaneEffects of Dexrazoxane on Healthy Human
University of Arkansas 25
Not applicableStudy completedNCT03339804
What this trial is testing

Neurovascular Changes Induced by Chemotherapy

Who this might be right for
Breast CancerChemotherapeutic Toxicity
University of Sao Paulo General Hospital 16
Not applicableStudy completedNCT02796365
What this trial is testing

Prevention Using Exercise Rehabilitation to Offset Cardiac Toxicities Induced Via Chemotherapy

Who this might be right for
Doxorubicin Induced CardiomyopathyBreast CancerGastric Cancer+1 more
Henry Ford Health System 29
Not applicableStudy completedNCT03027063
What this trial is testing

Impact of Exercise on Mitigating the Cardio-toxic Effects of Adriamycin Among Women Newly Diagnosed With Breast Cancer.

Who this might be right for
Breast Cancer FemaleAdriamycin Toxicity
Johns Hopkins University 21
Testing effectiveness (Phase 2)Study completedNCT00001165
What this trial is testing

Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas

Who this might be right for
Islet Cell AdenomaNeoplasm MetastasisZollinger Ellison Syndrome
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 999
Testing effectiveness (Phase 2)Study completedNCT03576521
What this trial is testing

Evaluation of Ocoxin®-Viusid® in Breast Cancer

Who this might be right for
Breast CancerBreast CarcinomaAdriamycin Toxicity+1 more
Catalysis SL 120
Not applicableEnded earlyNCT00352872
What this trial is testing

Pharmacogenetics as a Predictor of Toxicity in Pre-Menopausal Women Receiving Doxorubicin and Cyclophosphamide in Early Breast Cancer

Who this might be right for
Breast Cancer
Indiana University School of Medicine 23
Not applicableUnknownNCT05733026
What this trial is testing

Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Doxorubicin Among Egyptian Breast Cancer Patients

Who this might be right for
Breast Cancer
Ain Shams University 200
Testing effectiveness (Phase 2)UnknownNCT06176339
What this trial is testing

Assessing the Clinical Utility of Adding Pentoxifylline to Neoadjuvant Chemotherapy Protocols in Breast Cancer Patients"

Who this might be right for
Breast Cancer Female
Mansoura University 70
Testing effectiveness (Phase 2)Study completedNCT00222105
What this trial is testing

A Study Evaluating Efficacy, Toxicity, Harvest Yield and Quality of Life

Who this might be right for
Multiple Myeloma
University of Kansas Medical Center 25
Not applicableStudy completedNCT00577798
What this trial is testing

Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin

Who this might be right for
Cardiac ToxicityChemotherapeutic Agent ToxicityLymphoma
University of Nebraska 10
Not applicableStudy completedNCT03908528
What this trial is testing

Alpha-Lipoic Acid in Breast Cancer Patients

Who this might be right for
Breast CancerChemotherapeutic Toxicity
Damanhour University 64
Large-scale testing (Phase 3)Study completedNCT00245050
What this trial is testing

Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer

Who this might be right for
Breast CancerDrug/Agent Toxicity by Tissue/OrganEndometrial Cancer+3 more
Case Comprehensive Cancer Center 34
Large-scale testing (Phase 3)Ended earlyNCT00016276
What this trial is testing

Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer

Who this might be right for
Cardiac ToxicityInflammatory Breast CancerStage IIIA Breast Cancer+2 more
National Cancer Institute (NCI) 396
Load More Results